The Pharmaceutical Journal
Vol 276 No 7389 p225
25 February 2006

This article
Reprint   Photocopy

  Acrobat Reader

News summary

Monitoring ADRs

New software has been introduced at the Medicines and Healthcare products Regulatory Agency to analyse reported adverse drug reactions. It is expected to signal potential problems earlier and to improve the focus on reactions in children and pregnant women.